Evidence map›Paper›PMID 29887968›Full record

ArticleAmerican journal of translational research2018

Enrichment and characterization of cancer stem-like cells in ultra-low concentration of serum and non-adhesive culture system.

Junfeng Zhang, Yunsheng Zhang, Lin Cheng, Chunlei Li, Lei Dai, Hui Zhang, Fenglian Yan, Hui Shi, Guanjun Dong, Zhaochen Ning and 4 more

Erratum issuedAbstract read
In one paragraph

Article in American journal of translational research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Prostate cancer stem cells and their targeted therapies.Frontiers in cell and developmental biology · 2024
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Lung Cancer Stem Cells and Their Clinical Implications.Cold Spring Harbor perspectives in medicine · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Junfeng ZhangInstitute of Immunology and Molecular Medicine, Jining Medical University Jining 272067, Shandong, China.
Yunsheng ZhangInstitute of Immunology and Molecular Medicine, Jining Medical University Jining 272067, Shandong, China.
Lin ChengState Key Laboratory of Biotherapy/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University Chengdu, Sichuan, China.
Chunlei LiState Key Laboratory of Biotherapy/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University Chengdu, Sichuan, China.
Lei DaiState Key Laboratory of Biotherapy/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University Chengdu, Sichuan, China.
Hui ZhangInstitute of Immunology and Molecular Medicine, Jining Medical University Jining 272067, Shandong, China.
Fenglian YanInstitute of Immunology and Molecular Medicine, Jining Medical University Jining 272067, Shandong, China.
Hui ShiInstitute of Immunology and Molecular Medicine, Jining Medical University Jining 272067, Shandong, China.
Guanjun DongInstitute of Immunology and Molecular Medicine, Jining Medical University Jining 272067, Shandong, China.
Zhaochen NingInstitute of Immunology and Molecular Medicine, Jining Medical University Jining 272067, Shandong, China.
Wei XuShenzhen SiBiono GeneTech Co. Ltd. Shenzhen, China.
Chuanping SiInstitute of Immunology and Molecular Medicine, Jining Medical University Jining 272067, Shandong, China.
Hongxin DengState Key Laboratory of Biotherapy/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University Chengdu, Sichuan, China.
Huabao XiongInstitute of Immunology and Molecular Medicine, Jining Medical University Jining 272067, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer stem cells (CSCs) play important roles in tumor initiation, metastasis, and progression. They are also mainly responsible for high treatment failure rates. Identification and characterization of CSCs are crucial for facilitating the detection, prevention, or therapy of cancer. Great efforts have been paid to develop an effective method and the ideal method for CSCs research is still in the going. In our study, we created an ultra-low concentration of serum and non-adhesive (ULCSN) culture system to enrich CSCs from murine lewis lung cancer cell line LL/2 with cell spheres structure and characterize the LL/2 CSCs properties. Their characteristics were investigated through colony formation, spheres formation, chemoresistance, flow cytometry for putative stem cell markers, such as CD133, CD34 and CD45, immunofluorescence staining and tumor initiation capacity

Indexed as

cancerCancer stem cellscharacterizationmarker

Identifiers

PMID29887968
PMCPMC5992539

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.